3ao5
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | [[Image:3ao5.png|left|200px]] | ||
| - | + | ==Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase== | |
| + | <StructureSection load='3ao5' size='340' side='right'caption='[[3ao5]], [[Resolution|resolution]] 1.80Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[3ao5]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AO5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3AO5 FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BBY:5-(7-BROMO-1,3-BENZODIOXOL-5-YL)-1-METHYL-1H-PYRAZOL-3-AMINE'>BBY</scene>, <scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=FRU:FRUCTOSE'>FRU</scene>, <scene name='pdbligand=GLC:ALPHA-D-GLUCOSE'>GLC</scene>, <scene name='pdbligand=PRD_900003:sucrose'>PRD_900003</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ao5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ao5 OCA], [https://pdbe.org/3ao5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ao5 RCSB], [https://www.ebi.ac.uk/pdbsum/3ao5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ao5 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/Q72498_9HIV1 Q72498_9HIV1] | ||
| - | == | + | ==See Also== |
| - | + | *[[Retroviral integrase 3D structures|Retroviral integrase 3D structures]] | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | [[ | + | |
| - | + | ||
| - | + | ||
| - | < | + | |
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Chalmers DK]] |
| - | [[Category: | + | [[Category: Headey SJ]] |
| - | [[Category: | + | [[Category: Parker MW]] |
| - | [[Category: | + | [[Category: Scanlon MJ]] |
| - | [[Category: | + | [[Category: Wielens J]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase
| |||||||||||
